The Third Circuit on Thursday backed the dismissal of an antitrust suit alleging Pfizer Inc. and Ranbaxy Laboratories Ltd. conspired to delay the market entry of a generic version of the cholesterol drug Lipitor, ruling that the plaintiffs lacked standing.
By George Woolston ( August 13, 2026, 6:40 PM EDT) -- The Third Circuit on Thursday backed the dismissal of an antitrust suit alleging Pfizer Inc. and Ranbaxy Laboratories Ltd. conspired to delay the market entry of a generic version of the cholesterol drug Lipitor, ruling that the plaintiffs lacked standing....
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
And more!
Experience Law360 today with a free 7-day trial.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Fed. Circ. Doubts $9M Atty Fees Without Dismissal Attempt | -2 | 6 | 09-07-2026 |
| 2 | Bristol-Myers Can't Duck UMB Suit Targeting Drug Approvals | 0 | 11.22 | 13-08-2026 |
| 3 | Court OKs Antitrust Deal Over Allegheny Health's Expansion | 0 | 5 | 26-06-2026 |
| 4 | 3rd Circ. Backs Arbitrators' Change To Investment Fee Award | 0 | 10.41 | 05-08-2026 |
| 5 | 9th Circ. Affirms Dismissal Of Investor Suit Against SunPower | 0 | 6.05 | 24-07-2026 |
| 6 | Pharma Co. Beats Investor Suit Over Prostate Drug Trial | 0 | 5 | 16-07-2026 |
| 7 | 5th Circ. Affirms Defeat Of French Co.'s Bid For Exxon Docs | 0 | 6.33 | 24-07-2026 |
| 8 | 3rd Circ. Won't Give Ex-Olympus Exec Another Go At FCA Suit | 0 | 8.21 | 04-08-2026 |
| 9 | 3rd Circ. Won't Give Ex-Olympus Exec Another Go At FCA Suit | 0 | 8.21 | 04-08-2026 |